ClinicalTrials.govpublic full text
Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis
amyotrophic lateral sclerosis, motor neuron disease, neuromuscular disease, neurodegenerative disease, central nervous system disease, als, bone marrow derived stem cell, stem cell therapy, intrathecal injection, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856673
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.